Connect with us


Kaya Brands International, Inc, A Subsidiary Of Kaya Holdings Inc (OTCMKTS:KAYS), And Greekkannabis Will Introduce CBD Pet Products Under Cannamo Brand



Kaya Brands International, Inc. (KBI), an auxiliary of Kaya Holdings Inc (OTCMKTS:KAYS), along with its JV partner – Greekkannabis (GKC) will roll out cannabidiol pet products under the brand – Cannamo in Greece and adjoining nations in Europe.

Involves Day Three Labs

KBI developed the Cannomo brand to satisfy the demand identified by GKC. The company also involved Day Three Labs (DTL), a company based in Israeli, developing the Cannamo brand.

GKC will contribute experience gained in the pet supplement and pet food industry in Greece for the success of this innovative brand. The three partners will play a vital role in introducing the Cannamo brand and facilitating its penetration.

Craig Frank, CEO of Kayak, said the Cannamo brand is a result of the three players’ broader cooperation to establish a large company for global expansion. The three leading players leveraged their strengths in the development and commercialization of the Cannamo brand and make its implementation simple and effective.

Kaya Kannabis, a JV between GKC and Kaya, will nurture relationships with customers for CBD products introduced by the team while rigorous efforts are put in to create a marketing strategy targeted at the EU. Co-founder of GKC, Elias Kammenos, said the launch of CBD pet products will generate revenue streams while a medical cannabis facility is constructed in Greece. It will also familiarize its brands in the EU because plans are underway to introduce THC products.

DTL’s principals – Rafi Cohen and Joshua Robin will be onboard the advisory panel to support the construction of the cultivation and processing project of Kayak in Israel. Craig said the company is excited to work with DTL on mutually beneficial projects. Kayak will benefit from product development and relationships in the scientific cannabis community of Israel.

Long time opportunity

Co-founder of GKC, Panos Kinnis, said their innovative ideas, approach, and vision helped expedite the launch of its products. It also offered a myriad of opportunities to cultivate growth. EU presents a long time demand for cannabidiol and medical cannabis products. GKC plans to go ahead with KBI to take an early lead and capitalize on the emerging opportunities to derive rich dividends.

The Greek government granted a cannabis installation license to GKC to commence Medical Cannabis Cultivation/ processing facility in Thebes, Greece. It will annually produce 225,000 pounds of medical cannabis products. Kayak established KBI to address global markets, leveraging its operational expertise.

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.